Cargando…

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk

Psoriasis is a systemic, relapsing, inflammatory disease associated with serious comorbidities including mood problems and/or unhealthy lifestyle behaviours. Cutaneous and systemic abnormalities in innate and acquired immunity play a role in its pathogenesis. The exact pathogenetic mechanism remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	KLEYN, C. Elise, TALBOT, Peter S., MEHTA, Nehal N., SAMPOGNA, Francesca, BUNDY, Chris, ASHCROFT, Darren M., KIMBALL, Alexa B., VAN DE KERKHOF, Peter, GRIFFITHS, Christopher E. M., VALENZUELA, Fernando, VAN DER WALT, Joelle M., ABERRA, Tsion, PUIG, Lluís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128964/ https://www.ncbi.nlm.nih.gov/pubmed/31742649 http://dx.doi.org/10.2340/00015555-3375

Ejemplares similares

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
por: Cohen, Arnon D., et al.
Publicado: (2020)

Clinical Goals and Barriers to Effective Psoriasis Care
por: Strober, Bruce E., et al.
Publicado: (2018)

Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis
por: HEWITT, Rachael M., et al.
Publicado: (2021)

Getting under the Skin: Report from the International Psoriasis Council Workshop on the Role of Stress in Psoriasis
por: Schwartz, Julia, et al.
Publicado: (2016)

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
por: Strober, Bruce, et al.
Publicado: (2019)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Brain structure and connectivity in psoriasis and associations with depression and inflammation; findings from the UK biobank
por: Lada, Georgia, et al.
Publicado: (2022)

The effect of the Covid‐19 pandemic on illness perceptions of psoriasis and the role of depression: Findings from a cross‐sectional study
por: Lada, Georgia, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on the Mental Health and Quality of Life of Patients with Psoriasis in Tertiary Care; A One-year Follow-up
por: LADA, Georgia, et al.
Publicado: (2022)

Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK
por: Chen, Teng-Chou, et al.
Publicado: (2023)

An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis
por: PUIG, Lluís, et al.
Publicado: (2020)

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
por: Thorneloe, R.J., et al.
Publicado: (2016)

Pathophysiology of Generalized Pustular Psoriasis
por: Marrakchi, Slaheddine, et al.
Publicado: (2022)

Associations between psoriatic arthritis and mental health among patients with psoriasis: A replication and extension study using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
por: Lada, Georgia, et al.
Publicado: (2022)

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
por: Puig, Lluís
Publicado: (2017)

Genetic and Epigenetic Mechanisms of Psoriasis
por: Mateu-Arrom, Laura, et al.
Publicado: (2023)

The global state of psoriasis disease epidemiology: a workshop report
por: Griffiths, C.E.M., et al.
Publicado: (2017)

An Assessment of the Cost-Utility of Therapy for Psoriasis
por: Weiss, Stefan C, et al.
Publicado: (2006)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
por: van de Kerkhof, P.C.M., et al.
Publicado: (2015)

A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain
por: Puig, L., et al.
Publicado: (2017)

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
por: Kimball, Alexa B., et al.
Publicado: (2021)

Update on biologic safety for patients with psoriasis during pregnancy
por: Porter, Martina L., et al.
Publicado: (2017)

Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study
por: Klein, Toni Maria, et al.
Publicado: (2021)

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
por: Krueger, James, et al.
Publicado: (2022)

Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities
por: Bronckers, I. M. G. J., et al.
Publicado: (2015)

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
por: Yélamos, Oriol, et al.
Publicado: (2015)

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists
por: Gonzalez-Cantero, Alvaro, et al.
Publicado: (2023)

Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
por: Camiña-Conforto, Gemma, et al.
Publicado: (2023)

Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
por: Teklu, Meron, et al.
Publicado: (2021)

Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis
por: PAPP, Kim, et al.
Publicado: (2022)

Quality of Life of Psoriasis Patients before and after Balneo - or Balneophototherapy
por: Tabolli, Stefano, et al.
Publicado: (2009)

Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3
por: Ogdie, Alexis, et al.
Publicado: (2015)

Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups
por: VAN WINDEN, Marieke E. C., et al.
Publicado: (2020)

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
por: Mason, K.J., et al.
Publicado: (2019)

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis
por: Sarma, Nilendu
Publicado: (2017)

TARGETING IL-23: INSIGHTS INTO THE PATHOGENESIS AND THE TREATMENT OF PSORIASIS
por: Lima, Hermenio Cavalcante, et al.
Publicado: (2010)

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis
por: Luna, Paula C., et al.
Publicado: (2023)

Safety of treatment with biologics for psoriasis in daily practice: 5-year data
por: Van Lümig, PPM, et al.
Publicado: (2010)

Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis
por: Valenzuela, Fernando, et al.
Publicado: (2022)

Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis
por: Langewouters, A. M. G., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3l3gcs5n82iij9t9akd0uktrn5